Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With Rosacea
Clinical trial NCT02289352 · COMPLETED
Trial details
- NCT number
- NCT02289352
- Sponsor
- Actavis Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2014-12-01
- Enrollment
- 462
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.